Endotelio

Upcoming events

About

Company description

PHARMENA SA is a dynamically developing, publicly traded biotechnology company. Our core business is the development and commercialization of innovative products based on the patented, physiological, and natural active ingredient 1-MNA.

The company's activities focus on clinical trials of an innovative anti-inflammatory and anti-fibrotic drug and on the market launch of an innovative medical device and dietary supplements used to meet specific nutritional needs.

We invite you to familiarize yourself with our projects.

Upcoming events